Literature DB >> 23727170

Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention.

Ron T Gansevoort1, Ricardo Correa-Rotter, Brenda R Hemmelgarn, Tazeen H Jafar, Hiddo J Lambers Heerspink, Johannes F Mann, Kunihiro Matsushita, Chi Pang Wen.   

Abstract

Since the first description of the association between chronic kidney disease and heart disease, many epidemiological studies have confirmed and extended this finding. As chronic kidney disease progresses, kidney-specific risk factors for cardiovascular events and disease come into play. As a result, the risk for cardiovascular disease is notably increased in individuals with chronic kidney disease. When adjusted for traditional cardiovascular risk factors, impaired kidney function and raised concentrations of albumin in urine increase the risk of cardiovascular disease by two to four times. Yet, cardiovascular disease is frequently underdiagnosed and undertreated in patients with chronic kidney disease. This group of patients should, therefore, be acknowledged as having high cardiovascular risk that needs particular medical attention at an individual level. This view should be incorporated in the development of guidelines and when defining research priorities. Here, we discuss the epidemiology and pathophysiological mechanisms of cardiovascular risk in patients with chronic kidney disease, and discuss methods of prevention.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23727170     DOI: 10.1016/S0140-6736(13)60595-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  598 in total

1.  Plasma levels of microRNA in chronic kidney disease: patterns in acute and chronic exercise.

Authors:  Amaryllis H Van Craenenbroeck; Kristien J Ledeganck; Katrijn Van Ackeren; Angelika Jürgens; Vicky Y Hoymans; Erik Fransen; Volker Adams; Benedicte Y De Winter; Gert A Verpooten; Christiaan J Vrints; Marie M Couttenye; Emeline M Van Craenenbroeck
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-16       Impact factor: 4.733

2.  Targeting Blood Vessel Stiffness to Protect Kidney Function.

Authors:  Neeraj Dhaun; David J Webb
Journal:  Clin J Am Soc Nephrol       Date:  2015-11-12       Impact factor: 8.237

3.  Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco Scardapane; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

Review 4.  Concise Review: Kidney Generation with Human Pluripotent Stem Cells.

Authors:  Ryuji Morizane; Tomoya Miyoshi; Joseph V Bonventre
Journal:  Stem Cells       Date:  2017-09-26       Impact factor: 6.277

5.  Assessment of physical performance and body composition in male renal transplant patients.

Authors:  Andrea Petronio Rossi; Gianluigi Zaza; Marina Zanardo; Francesco Pedelini; Laura Dalla Verde; Chiara Caletti; Alessia D'Introno; Antonio Lupo; Mauro Zamboni
Journal:  J Nephrol       Date:  2018-03-17       Impact factor: 3.902

6.  Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.

Authors:  Ling Lin; Qiuxia Xie; Mei Zheng; Xuhui Zhou; Ilona A Dekkers; Qian Tao; Hildo J Lamb
Journal:  Eur Radiol       Date:  2021-02-24       Impact factor: 5.315

7.  Independent and interactive effects of kidney stone formation and conventional risk factors for chronic kidney disease: a follow-up study of Japanese men.

Authors:  Ryosuke Ando; Teruo Nagaya; Sadao Suzuki; Hidekatsu Takahashi; Makoto Kawai; Kazumi Taguchi; Shuzo Hamamoto; Atsushi Okada; Takahiro Yasui
Journal:  Int Urol Nephrol       Date:  2021-02-24       Impact factor: 2.370

8.  Cardiovascular outcome trials in patients with chronic kidney disease: challenges associated with selection of patients and endpoints.

Authors:  Patrick Rossignol; Rajiv Agarwal; Bernard Canaud; Alan Charney; Gilles Chatellier; Jonathan C Craig; William C Cushman; Ronald T Gansevoort; Bengt Fellström; Dahlia Garza; Nicolas Guzman; Frank A Holtkamp; Gerard M London; Ziad A Massy; Alexandre Mebazaa; Peter G M Mol; Marc A Pfeffer; Yves Rosenberg; Luis M Ruilope; Jonathan Seltzer; Amil M Shah; Salim Shah; Bhupinder Singh; Bergur V Stefánsson; Norman Stockbridge; Wendy Gattis Stough; Kristian Thygesen; Michael Walsh; Christoph Wanner; David G Warnock; Christopher S Wilcox; Janet Wittes; Bertram Pitt; Aliza Thompson; Faiez Zannad
Journal:  Eur Heart J       Date:  2019-03-14       Impact factor: 29.983

9.  Association of Albuminuria With Cardiac Dysfunction in US Hispanics/Latinos.

Authors:  David B Hanna; Shuo Xu; Michal L Melamed; Franklyn Gonzalez; Matthew A Allison; Martin S Bilsker; Barry E Hurwitz; Mayank M Kansal; Neil Schneiderman; Sanjiv J Shah; Robert C Kaplan; Carlos J Rodriguez; Jorge R Kizer
Journal:  Am J Cardiol       Date:  2017-03-29       Impact factor: 2.778

Review 10.  Heart failure and kidney dysfunction: epidemiology, mechanisms and management.

Authors:  Joerg C Schefold; Gerasimos Filippatos; Gerd Hasenfuss; Stefan D Anker; Stephan von Haehling
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.